This site uses cookies

To give you the best possible experience, the GAM website uses cookies. You can read full information of our cookie use here. Your privacy is important to us and we encourage you to read our privacy policy here.

OK

Mark Hawtin

Mark Hawtin - Investment Director


Mark Hawtin is the investment director responsible for running global long only and long/short funds investing in the disruptive growth & technology sectors.

Prior to joining GAM in October 2008, he was a partner and portfolio manager with Marshall Wace Asset Management for eight years, managing one of Europe’s largest technology, media and telecoms hedge funds. Mark Hawtin previously spent seven years at Enskilda Securities, initially as head of sales, before taking responsibility for the international equity business, overseeing pan-European research and trading activities and around a quarter of the investment banking staff. He is based in London.

Mark Hawtin

My Insights

Weekly Manager Views

2 min read

Weekly Manager Views: Equities
04 March 2021

At GAM Investments’ latest Equities Meeting, held on 2 March, two of our managers shared their thoughts on inflation, interest rates and corporate earnings.

Investment Opinions

12 min read

Disruption in 2021 and beyond
19 January 2021

As part of the inaugural edition of ‘The Disruptive Strategist’, an in-depth and thoughtful assessment of the investment universe, GAM Investments’ Mark Hawtin and the disruptive growth team considered disruptive trends for 2021 and beyond.

Investment Opinions

5 min read

IPO bubble - when will it burst?
21 December 2020

Valuations in parts of the disruptive technology universe are increasingly stretched, particularly in the initial public offering (IPO) arena. GAM Investments’ Mark Hawtin believes an intrinsic valuation-based approach to investment is now paramount to avoid pitfalls.

Weekly Manager Views

2 min read

Weekly Manager Views: Equities
13 November 2020

At GAM Investments’ latest Equities Meeting, held on 27 October, our managers shared their views on Covid-19 vaccine developments and equity markets globally.